Charles River Laboratories International, Inc. (CRL) Stock Analysis

Charles River Laboratories International, Inc. (CRL) Stock Analysis — AI Research | MarketCI

CRL

Market Closed

Charles River Laboratories International, Inc.

NYSEHealthcare Medical - Diagnostics & Research

18.70K employees

CEO: James C. Foster

Founded: 2000

$185.00

+$0.00(+NaN%)

Market Cap

8.91B

Beta

1.45

52W Range

N/A

Dividend Yield

0.00%

Overview Forecasts Fundamental Market Sentiment Valuation Ownership

CRL Price Chart

Historical price performance

Loading MCI price data...

MarketCI Investment Signals

AI-synthesized investment signal for CRL built from valuation, fundamentals, sentiment, and risk models

Investment Signal

Strong Sell

Pass %

28.57%

Score

2/7

Fair Value Estimate

Cash flow analysis • Multiple methods

$107.34

AI Price Target

Machine learning • Price prediction

$170.04

Market Sentiment

News & social media analysis

0.03

Value Investor Price

Classic value analysis

$0.00

Financial Health

Bankruptcy risk assessment

2.11

Quality Score

Financial strength rating

4.00

AI Investment Grade

Deep analysis of filings & news

75.00

Key Investment Highlights

Important factors affecting CRL investment thesis

Due Diligence Analysis

Investment criteria assessment and scoring

Overall Assessment

51.35% Good

Conditions Met

19.00/37.00

Due Diligence Score

51.35%

Due Diligence Conditions

Investment analysis conditions and results


	Fail
	Fail
	Pass
	Fail
	Fail
	Fail

Showing 1 to 6 of 46 conditions